User:Mr. Ibrahem/Levodopa/benserazide

Levodopa/benserazide, also known as co-beneldopa and sold under the brand name Prolopa among others, is a combination medication used to treat Parkinson disease. It is taken by mouth.

Common side effects include anxiety, depression, heart arrhythmias, hallucinations, low blood pressure with standing, and loss of appetite. Other side effects can include impulse control disorders and sudden sleepiness. It is not recommended in those with severe liver problems. Stopping suddenly may result in severe muscle breakdown. It is composed of levodopa, a dopamine agonist and benserazide, a decarboxylase inhibitor.

The combination was approved for medical use in Canada in 1977. It is on the World Health Organization's List of Essential Medicines as an alternative to levodopa/carbidopa. In the United Kingdom a 100 tablets costs the NHS about £10 as of 2023.